Zusammenfassung
Erkrankungen, die mit chronischer Entzündung oder mit Autoimmunprozessen einhergehen, weisen ein erhöhtes Risiko für die Entwicklung der Osteopenie oder einer sekundären Osteoporose auf: z.B. die chronische Sinusitis, die rheumatoide Arthritis, chronisch entzündliche Darmerkrankungen, oder der Diabetes-mellitus-Typ-1 (Antonelli et al. 1992, Ziegler 1992, Scharia et al. 1994).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Adachi JD, Bensen WG, Bianchi F, Cividino A, Pillersdorf S, Sebaldt RJ, Tugwell P, Gordon M, Steele M, Webber C, Goldsmith CH (1996) Vitamin D and Calcium in the prevention of corticosteroid induced osteoporosis: A 3 year follow up. J Rheumatol 23:995–1000
Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie L-G, Tenenhouse A, Chines AA (1997) Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 337:382–387
Antonelli PJ, Duvall AJ 3rd, Teitelbaum SL (1992) Maxillary sinus atelectasis. Ann Otol Rhinol Laryngol 101:977–981
Bijlsma JWJ (1988) Bone metabolism in patients with rheumatoid arthritis. Clin Rheumatol 7:16–23
Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM (1996) Calcium and Vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 125:961–968
Canalis E (1996) Mechanism of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis. J Clin Endocrino Metab 81:3441–3447
Centrella M, McCarthy TL, Canalis E (1988) Tumor necrosis factor-a inhibits collagen synthesis and alkaline Phosphatase activity independently of its effect on deoyribo-nucleic acid synthesis in osteoblast-enriched bone cell cultures. Endocrinology 123:1442–1448
Crilly R, Marshall DH, Cawood M, Nordin BEC (1978) Hormonal status in normal osteoporotic and corticosteroid-treated postmenopausal woman. Proc R Soc Med 71:733–736
Dequeker J, Geusens P (1990) Osteoporosis and arthritis. Ann Rheum Dis 49:276–280
Dequeker J, Linthoudt H, Vanschoubroeck I, Van Cleemput J, Geusens P (1994) Prevention of postmenopausal bone loss by 1a Vitamin D3. Aktuel Rheumatol 19 (Suppl):19–22
Evans DB, Thavarajah M, Kanis JA (1990) Involvement of Prostaglandin E2 in the inhibition of osteocalcin synthesis by human osteoblast-like cells in response to cytokines and systemic hormones. Biochem Biophys Res Commun 167:194–202
Godschalk MF, Downs RW (1988) Effect of Short-Term Glucocorticoids on Serum Osteocalcin in Healthy Young Men. J Bone Miner Res 3:113–114
Hattersley AT, Meeran K, Burrun J, et al (1994) The effect of long-term and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels. Calcif Tissue Int 54:198–202
Hofbauer LC, Dunstan CR, Speisberg TC, Riggs BL, Khosla S (1998) Osteoprotegerin production by human Osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Com 250:776–778
Lane NE, Pressman AR, Star VL, Cummings SR, Nevitt MC, et al (1995) Rheumatoid Arthritis and Bone Mineral Density in Elderly Woman. J Bone Miner Res 10:257–263
Lemire JM (1995) Immunomodulatory Actions of 1,25-Dihydroxyvitamin D3. J Steroid Biochem Molec Biol 53:599–602
Lembert UG, Minne HW, Albrecht B, Scharia SH, Matthes F, Ziegler R (1989) 1,25-dihydroxivitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO). Bone and Mineral 7:149–158
Minne HW, Pfeilschifter J, Scharia S, Mutschelknauss S, Schwarz A, Krempien B, Ziegler R (1994) Inflammation mediated osteopenia in the rat: A new animal model for pathological loss of bone mass. Endocrinology 115:50–54
Müller K, Diamant M, Bendtzen K (1991) Inhibition of production and function of interleukin-6 by 1,25-dihydroxivitamin D3. Immunology Letters 28:115–120
Nanes MS, McKoy WM, Marx SJ (1989) Inhibitory effects of tumor necrosis factor-a and interferon-γ on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8). Endocrinology 124:339–345
Nanes MS, Rubin J, Titus L, Hendy GN, Catherwood B (1991) Tumor necrosis factor-a inhibits 1,25-dihydroxivitamin D3-stimulated bon Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism. Endocrinology 128:2577–2582
Oelzner P, Müller A, Deschner F, Hüller M, Abendroth K, Hein G, Stein G (1997) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193–198
Pearce G, Tabensky A, Delmas PD, Baker HWG, Seeman E (1998) Corticosteroid-Induced Bone Loss in Men. J Clin Endocrinol Metab 83:801–806
Reid DM, Hughes RA, Laan RFJM, Sacco-Gibson NA, Wenderoth DH, Adami S, Eusebio R, Devogelaer JP (2000) Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized Trial. J Bone Miner Res 5:1006–1013
Ringe JD (1998) Treatment of corticosteroid-induced osteoporosis with calcium/vitamin D versus Alfacalcidol. Zeitschrift für Rheumatologie 57 (Supplement 1):6 (abstract V6)
Saag KG, Emkey R, Schnitzler TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 339:292–299
Scharia SH, Schmidt-Gayk H, Sattar P (1984) Excusion of autonomous 1,25 (OH) 2-vitamin D3 (calcitriol) formation as a pathogenetic principle of inflammationmediated osteopenia (IMO). Acta endocrinologica 105 (Suppl 264):7
Scharia SH, Strong DD, Mohan S, Linkhart TA (1993) Effect of 1,25-Dihydroxyvitamin D3 on the secretion of insulin-like growth factor-II (IGF-II) and IGF-binding proteins (IGFBPs) in human osteoblast-like cells. Exp Clin Endocrinol 101 (Supplement 1):69 (abstract #90)
Scharia SH, Minne HW, Lempert UG, Leidig G, Hauber M, Raedsch R, Ziegler R (1994) Bone mineral density and calcium regulating hormones in patiens with inflammatory bowel disease (Crohn’s disease and ulcerative colitis). Exp Clin Endocrinology 102:44–49
Scharia SH, Strong DD, Mohan S, Chevalley T, Linkhart TA (1994) Effect of tumor necrosis factor-a on the expression of insulin-like growth factor I and insulin-like growth factor binding protein 4 in mouse osteoblasts. Eur J Endocrinol 131:293–301
Scharia SH, Bawey S; Holle D, Boensch J, Kamilli I, Quade E, Lempert UG (2000) Alfacalcidol inhibits bone resorption, modulates cytokines and reduces pain in patients with rheumatiod arthritis and osteopenia. Exp Clin Endocrinol Diabetes 108 (suppl)
Shultz TD, Kumar R (1987) Effect of Cortisol on (3H) 1,25-Dihydroxyvitamin D3 uptake and 1,25-Dihydroxyvitamin D3-induced DNA-dependent RNA Polymerase activity in chick intestinal cells. Calcif Tissue Int 40:224–230
Ziegler R (1992) Diabetes mellitus and bone metabolism. Horm Metab Res 26 (Suppl.):90–94
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scharla, S.H. (2002). Sekundäre Osteoporose bei rheumatoider Arthritis. In: Hedtmann, A., Götte, S. (eds) Osteoporose. Praktische Orthopädie, vol 41. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57442-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-57442-9_12
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-7985-1300-6
Online ISBN: 978-3-642-57442-9
eBook Packages: Springer Book Archive